These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9802387)

  • 1. Discontinuation of venom immunotherapy.
    Golden DB
    J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):703-4. PubMed ID: 9802387
    [No Abstract]   [Full Text] [Related]  

  • 2. Discontinuation of yellow jacket venom immunotherapy: follow-up of 75 patients by means of deliberate sting challenge.
    van Halteren HK; van der Linden PW; Burgers JA; Bartelink AK
    J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 1):767-70. PubMed ID: 9438484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hymenoptera venom immunotherapy: Past, present, and future.
    Oppenheimer J; Golden DBK
    Ann Allergy Asthma Immunol; 2018 Sep; 121(3):276-277. PubMed ID: 29909053
    [No Abstract]   [Full Text] [Related]  

  • 4. Wasp Venom Immunotherapy in a Patient With Immune-Mediated Inflammatory Central Nervous System Disease: Is it Safe?
    Nittner-Marszalska M; Kowal A; Szewczyk P; Guranski K; Ejma M
    J Investig Allergol Clin Immunol; 2017; 27(2):127-129. PubMed ID: 28398199
    [No Abstract]   [Full Text] [Related]  

  • 5. Mary Hewitt Loveless, MD: The origin of venom immunotherapy.
    Galli SJ
    Ann Allergy Asthma Immunol; 2018 Sep; 121(3):268-271. PubMed ID: 29964225
    [No Abstract]   [Full Text] [Related]  

  • 6. Venom immunotherapy: worth the time and trouble!
    Heddle RJ; Brown SG
    Clin Exp Allergy; 2009 Jun; 39(6):774-6. PubMed ID: 19533838
    [No Abstract]   [Full Text] [Related]  

  • 7. Sublingual immunotherapy with venom for patients with Hymenoptera venom allergy.
    Patriarca G; Nucera E; Roncallo C; Aruanno A; Lombardo C; Decinti M; Pascolini L; Milani M; Buonomo A; Schiavino D
    J Allergy Clin Immunol; 2009 Aug; 124(2):385; author reply 385-6. PubMed ID: 19482349
    [No Abstract]   [Full Text] [Related]  

  • 8. Rush Hymenoptera venom immunotherapy: successful treatment in a patient with systemic mast cell disease.
    Engler RJ; Davis WS
    J Allergy Clin Immunol; 1994 Sep; 94(3 Pt 1):556-9. PubMed ID: 8083461
    [No Abstract]   [Full Text] [Related]  

  • 9. [Highly purified toxin extracts for desensitization. Insect-sting allergy: a causal treatment is possible].
    MMW Munch Med Wochenschr; 1979 Aug; 121(34):1057. PubMed ID: 114755
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy control of specific hymenoptera venom allergy].
    Aust W; Wichmann G; Dietz A
    Laryngorhinootologie; 2010 Dec; 89(12):725-8. PubMed ID: 21132618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hymenoptera sting anaphylaxis and urticaria pigmentosa: clinical findings and results of venom immunotherapy in ten patients.
    Fricker M; Helbling A; Schwartz L; Müller U
    J Allergy Clin Immunol; 1997 Jul; 100(1):11-5. PubMed ID: 9257781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intolerance of specific immunotherapy with Hymenoptera venom: jumping the hurdle with omalizumab].
    Wieczorek D; Kapp A; Wedi B
    Hautarzt; 2014 Sep; 65(9):791-5. PubMed ID: 25234627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A controlled trial of immunotherapy in insect hypersensitivity.
    Hunt KJ; Valentine MD; Sobotka AK; Benton AW; Amodio FJ; Lichtenstein LM
    N Engl J Med; 1978 Jul; 299(4):157-61. PubMed ID: 78446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of hyposensitization with bee and wasp venom].
    Adolph J; Dehnert I; Fischer JF; Wenz W
    Z Erkr Atmungsorgane; 1986; 166(1):119-24. PubMed ID: 3953108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rush hymenoptera venom immunotherapy is efficacious and safe.
    Pasaoglu G; Sin BA; Misirligil Z
    J Investig Allergol Clin Immunol; 2006; 16(4):232-8. PubMed ID: 16889280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initiating yellow jacket venom immunotherapy with a 100-μg dose: A challenge?
    Vos BJPR; Dubois AEJ; Rauber MM; Pfützner W; Miehe M; Bohle B; Möbs C; Oude Elberink JNG
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1332-1334.e4. PubMed ID: 30240885
    [No Abstract]   [Full Text] [Related]  

  • 17. The impact of national guidelines on venom immunotherapy practice in the United Kingdom.
    Diwakar L; Ewan P; Huber PA; Clark A; Nasser S; Krishna MT
    Clin Exp Allergy; 2016 May; 46(5):749-53. PubMed ID: 26989871
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety profile of hymenoptera venom immunotherapy (VIT) in monosensitized patients: lack of new sensitization to nontreated insect venom.
    Spoerl D; Bircher AJ; Scherer K
    J Investig Allergol Clin Immunol; 2011; 21(1):22-7. PubMed ID: 21370719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of specific IgE and IgG4 measurements in the follow-up of a hymenoptera venom immunotherapy treatment: apropos of 82 cases].
    Sonneville A; Loustanau O; Tahar HA; Menelet I
    Allerg Immunol (Paris); 2000 Jan; 32(1):20-5. PubMed ID: 10723532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Is desensitization always indicated in allergy to insect venoms?].
    Prybilla B; Ruëff F
    Dtsch Med Wochenschr; 1994 Aug; 119(31-32):1093-5. PubMed ID: 8055747
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.